Multiple Sclerosis - 242841 / 243036

Search for a StudyJoin our Volunteer Mailing List

Calculate your body mass index (BMI)

Weight

Feet

Inches

Your BMI

Back to list

Multiple Sclerosis - 242841 / 243036


Study Dates:

Study Dates are Flexible

Study Number

242841

Group

●  Multiple sclerosis

Compensation

Up to: $1,700

Gender

Male, Female, Smoker, Non-Smoker

Age

18-55 years old

BMI

18-45

Additional Information

Volunteers must be taking a stable dose of medication for their MS.

For more information call 1-800-797-2448

Details

This study is for patients with progressive or relapsing forms of multiple sclerosis. The purpose of this study is to learn about the safety, efficacy, and pharmacokinetics of elezanumab at two dose levels in patients with multiple sclerosis. To take part, you will be required to complete 2 screening visits. If you qualify after the screening visits, site staff will contact you regarding when you will be able to start the study. This study consists of 17 office visits over 76 weeks in addition to a 30-day screening period